Ambulatory Surgery Centers (ASCs) entered 2025 with strong patient volume, higher case complexity, and expanding payer mix. Yet despite this growth, most ASCs are reporting measurable declines in net collections, rising denials, and higher administrative costs. The trend is consistent across specialties, orthopaedics, GI, pain management, ophthalmology, podiatry, and ENT.
The most pressing question practice leaders are asking today is straightforward:
As a leading Ambulatory Billing Services Company, Finnastra has spent the last year analyzing revenue cycles across ASC networks, private practices, and multi-location outpatient facilities. Across our assessments, several revenue-draining patterns emerged, and many are tied to upcoming 2026 billing, coding, and compliance changes that will impact reimbursement even further.
This article breaks down the financial leaks ASCs are facing in 2025 and the new billing guidelines every ASC must prepare for in 2026.
ASCs are experiencing a 19–34% increase in denials tied to coding precision, particularly for high-acuity procedures and implant-driven cases.
Common failure points include:
Our Ambulatory Billing Services are designed to simplify coding complexity so providers can focus on care without risking compliance or reimbursement.
Across the industry, 23% of prior authorizations are still submitted with incomplete documentation, causing downstream cancellations, payment delays, and post-service denials.
Common gaps include:
When you work with a dedicated Ambulatory Billing Services Company like Finnastra, authorization workflows become airtight, standardized, and payer-aligned.
In 2025, CMS expanded bundling rules, resulting in:
ASCs operating on outdated billing logic are losing between 8% and 15% of total expected revenue per procedure.
These gaps accumulate quickly, especially in orthopedic and GI cases.
A large percentage of ASCs still rely on generalized workflows that fail to adapt to payer-specific requirements. The result?
Finastra’s experts streamline payer engagement with disciplined, analytics-driven AR protocols.
The 2026 regulatory wave is expected to be the most transformative update for ASCs in nearly a decade. Several key themes are emerging:
ASCs that lack coding experts will face higher denials and longer turnaround times.
Surgery Billing Experts like Finnastra ensure ASCs remain compliant and ahead of every coding update.
Billing quality metrics will directly influence reimbursement.
Our Ambulatory Billing Services are designed to simplify this shift by aligning clinical workflows with billing compliance expectations.
Here are some reflection points ASC administrators should review internally:
If your ASC is facing even one of these pain points, the financial impact will accelerate as 2026 guidelines roll out.
As a leading ASC Billing Company, Finnastra delivers a future-proofed billing model that fortifies revenue cycles against upcoming regulatory shifts.
Finastra positions your ASC not just to catch up, but to outperform industry benchmarks in reimbursement yield, clean-claim rate, denial mitigation, and cash flow stability.
The next 12 months will set the tone for which ASCs stay competitive and which fall behind. Reimbursement changes are accelerating, and revenue vulnerabilities are becoming more difficult to absorb.
When you work with a dedicated Ambulatory Billing Services Company like Finnastra, you gain a strategic billing partner equipped to protect your revenue, elevate coding accuracy, and future-proof your ASC against regulatory change.
If your ASC wants to improve collections, eliminate denials, and get ahead of the 2026 guidelines, Finnastra is ready to help.
✔ A meta-description for SEO
✔ A social media caption for LinkedIn & Instagram
✔ A header-outline for your website
✔ A compressed version for your newsletter
Just tell me what you want next.

